Not Valid for Submission
C93.1 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of chronic myelomonocytic leukemia. The code is not specific and is NOT valid for the year 2021 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.
Specific Coding for Chronic myelomonocytic leukemia
Non-specific codes like C93.1 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for chronic myelomonocytic leukemia:
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code C93.1:
Inclusion TermsInclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Chronic monocytic leukemia
- CMML with eosinophilia
Code AlsoCode Also
A "code also" note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction.
- , if applicable, eosinophilia D72.18
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code C93.1 are found in the index:
- - Leukemia, leukemic - C95.9
- LEUKEMIA MYELOMONOCYTIC CHRONIC-. a myelodysplastic myeloproliferative disease characterized by monocytosis increased monocytes in the bone marrow variable degrees of dysplasia but an absence of immature granulocytes in the blood.
Information for Patients
Chronic Myeloid Leukemia
Also called: CML, Chronic granulocytic leukemia, Chronic myelogenous leukemia
Leukemia is cancer of the white blood cells. White blood cells help your body fight infection. Your blood cells form in your bone marrow. In leukemia, the bone marrow produces abnormal white blood cells. These cells crowd out the healthy blood cells, making it hard for blood to do its work. In chronic myeloid leukemia (CML), there are too many granulocytes, a type of white blood cell.
Most people with CML have a gene mutation (change) called the Philadelphia chromosome.
Sometimes CML does not cause any symptoms. If you have symptoms, they may include:
- Weight loss
- Night sweats
- Pain or a feeling of fullness below the ribs on the left side
Tests that examine the blood and bone marrow diagnose CML. Treatments include chemotherapy, stem cell transplants, infusion of donated white blood cells following stem cell transplants, surgery to remove the spleen, and biologic and targeted therapies. Biologic therapy boosts your body's own ability to fight cancer. Targeted therapy uses substances that attack cancer cells without harming normal cells.
NIH: National Cancer Institute
- After chemotherapy - discharge (Medical Encyclopedia)
- Bone marrow transplant (Medical Encyclopedia)
- Bone marrow transplant - discharge (Medical Encyclopedia)
- Chronic myelogenous leukemia (CML) (Medical Encyclopedia)
[Learn More in MedlinePlus]